Technical & Business Model Considerations
Author(s)
Kyle Brown
Document Description
Presentation by Kyle Brown, a CEO of Innolyst, during the Research Daylong Symposium "GRADRx: Crafting a Plan for Rare Disease Drug Developement" at the 2009 Genetic Alliance Annual Conference.
Date Added
July 30, 2009
Keywords
2009 genetic alliance annual conference, research daylong symposium, grandrx: crafting a plan for rare disease drug development, discovering openness in health systems, innolyst, registry
Return to search results
Document Description
Presentation by Kyle Brown, a CEO of Innolyst, during the Research Daylong Symposium "GRADRx: Crafting a Plan for Rare Disease Drug Developement" at the 2009 Genetic Alliance Annual Conference.
Date Added
July 30, 2009
Keywords
2009 genetic alliance annual conference, research daylong symposium, grandrx: crafting a plan for rare disease drug development, discovering openness in health systems, innolyst, registry